Important pharmacy news and late-breaking industry information updated daily.

Patients with celiac disease or other gluten-related disorders face many challenges in attempting to completely eliminate gluten from their diet. Pharmacists can help by making sure their patient’s medications, vitamins, and herbal products do not contain measurable gluten.

FDA on Thursday took additional steps to increase patient access to insulin products, as well as certain other biological products set to transition regulatory pathways in March.

FDA has approved three drugs for OTC use through a process called a prescription (Rx)-to-OTC switch. All three will be marketed as nonprescription drugs and will no longer be available via prescription. They are

Eight million Americans have started crowdfunding campaigns through websites like GoFundMe to pay for medical expenses for themselves or someone in their households, according to the NORC at the University of Chicago survey released Wednesday.

HHS said Tuesday that it will provide expertise and reallocated funds to Sanofi Pasteur for the development of a vaccine against the 2019 novel coronavirus (COVID-19). Sanofi will use its egg-free, recombinant DNA platform to produce a candidate vaccine against the virus.

APhA, warning that importation jeopardizes patient safety and the security of the U.S. drug supply chain, has launched a grassroots effort and call to action to challenge FDA's December 23, 2019, proposed rule on importing drugs from Canada.

More than 20 state attorneys general have rejected an $18 billion offer from three major drug wholesalers aimed at settling litigation over their alleged role in the opioid crisis. At least 30 states have either sued the distributors or have been involved in talks to resolve claims.

More and more companies are marketing direct-to-consumer (DTC) tests for a growing range of health conditions and traits directly to consumers online or in stores, including in pharmacies. But the kits are often marketed without the proper evidence to support the results, and little regulation exists.

FDA on Thursday requested that Eisai Inc. voluntarily withdraw its drug lorcaserin (Belviq, Belviq XR) after a safety clinical trial found an increased occurrence of cancer. Eisai has submitted a request to voluntarily withdraw the drug.

New research highlights the need to keep medications in their child-resistant containers. The study—which involved calls to five U.S. poison control centers by researchers from CDC, Emory University School of Medicine, and the Georgia Poison Center—is published in the Journal of Pediatrics.